Clinical Trial Update: A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD [Phase 2]

View source ↗

Summary

This is a Phase IIb dose-ranging study evaluating a fixed-dose combination of ensifentrine and glycopyrrolate for chronic obstructive pulmonary disease; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ensifentrine (ensifentrine)
• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: RECRUITING